| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 1.6 | 3.5 | 5.7 | 4.1 | 8.2 | 2.9 | −64.3% | |
| Selling, general & administrative | 1.6 | 4.4 | 4.0 | 4.0 | 4.3 | 4.8 | +12.4% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 3.2 | 7.9 | 9.7 | 8.0 | 12.5 | 7.8 | −37.9% | |
| Operating income | (3.2) | (7.9) | (9.7) | (8.0) | (12.5) | (7.8) | +37.9% | |
| Interest expense | 0.2 | 0.0 | (0.1) | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | −4.8% | |
| Other income / expense | (0.1) | (0.0) | 0.1 | 0.2 | 0.2 | 0.2 | −4.8% | |
| Pre-tax income | (3.2) | (7.9) | (9.6) | (7.8) | (12.3) | (7.6) | +38.5% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (3.2) | (7.9) | (9.6) | (7.8) | (12.3) | (7.6) | +38.5% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (932.64) | (152.70) | (139.20) | (401.80) | (80.32) | (8.16) | +89.8% | |
| EPS, diluted (per share) | (932.64) | (152.70) | (139.20) | (399.81) | (80.32) | (8.16) | +89.8% | |
| EBITDA | (3.0) | (7.9) | (9.6) | 0.2 | (12.3) | (7.8) | +36.7% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 8.0 | 0.0 | 0.0 | — | |
| Weighted average shares (shares) | 3,470 | 52,053 | 69,066 | 19,400 | 153,000 | 926,192 | +505.4% | |
| Weighted average diluted shares (shares) | 3,470 | 52,053 | 69,066 | 19,496 | 153,000 | 926,192 | +505.4% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
